BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 25663103)

  • 1. Influence of image-defined risk factors on the outcome of patients with localised neuroblastoma. A report from the LNESG1 study of the European International Society of Paediatric Oncology Neuroblastoma Group.
    Monclair T; Mosseri V; Cecchetto G; De Bernardi B; Michon J; Holmes K
    Pediatr Blood Cancer; 2015 Sep; 62(9):1536-42. PubMed ID: 25663103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Image-defined risk factor assessment of neurogenic tumors after neoadjuvant chemotherapy is useful for predicting intra-operative risk factors and the completeness of resection.
    Irtan S; Brisse HJ; Minard-Colin V; Schleiermacher G; Galmiche-Rolland L; Le Cossec C; Elie C; Canale S; Michon J; Valteau-Couanet D; Sarnacki S
    Pediatr Blood Cancer; 2015 Sep; 62(9):1543-9. PubMed ID: 25820608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of image defined risk factors in localized neuroblastoma patients: Results of the GPOH NB97 trial.
    Simon T; Hero B; Benz-Bohm G; von Schweinitz D; Berthold F
    Pediatr Blood Cancer; 2008 May; 50(5):965-9. PubMed ID: 17914735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history and biology of stage A neuroblastoma: a Pediatric Oncology Group Study.
    Alvarado CS; London WB; Look AT; Brodeur GM; Altmiller DH; Thorner PS; Joshi VV; Rowe ST; Nash MB; Smith EI; Castleberry RP; Cohn SL
    J Pediatr Hematol Oncol; 2000; 22(3):197-205. PubMed ID: 10864050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete surgical resection improves outcome in INRG high-risk patients with localized neuroblastoma older than 18 months.
    Fischer J; Pohl A; Volland R; Hero B; Dübbers M; Cernaianu G; Berthold F; von Schweinitz D; Simon T
    BMC Cancer; 2017 Aug; 17(1):520. PubMed ID: 28778185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of image-defined risk factors with clinical features, tumor biology, and outcomes in neuroblastoma: a single-center retrospective study.
    Yang DD; Liu C; Gao J; Hu QJ; Liang Y; Liu J
    Eur J Pediatr; 2023 May; 182(5):2189-2196. PubMed ID: 36856889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Image-defined risk factors in unresectable neuroblastoma: SIOPEN study on incidence, chemotherapy-induced variation, and impact on surgical outcomes.
    Avanzini S; Pio L; Erminio G; Granata C; Holmes K; Gambart M; Buffa P; Castel V; Valteau Couanet D; Garaventa A; Pistorio A; Cecchetto G; Martucciello G; Mattioli G; Sarnacki S
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28440012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of surgery in the treatment of patients with high-risk neuroblastoma who have a poor response to induction chemotherapy.
    Du L; Liu L; Zhang C; Cai W; Wu Y; Wang J; Lv F
    J Pediatr Surg; 2014 Apr; 49(4):528-33. PubMed ID: 24726106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical risk factors in primary surgery for localized neuroblastoma: the LNESG1 study of the European International Society of Pediatric Oncology Neuroblastoma Group.
    Cecchetto G; Mosseri V; De Bernardi B; Helardot P; Monclair T; Costa E; Horcher E; Neuenschwander S; Tomà P; Rizzo A; Michon J; Holmes K
    J Clin Oncol; 2005 Nov; 23(33):8483-9. PubMed ID: 16293878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management and outcome of stage 3 neuroblastoma.
    Modak S; Kushner BH; LaQuaglia MP; Kramer K; Cheung NK
    Eur J Cancer; 2009 Jan; 45(1):90-8. PubMed ID: 18996003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Image-defined Risk Factors Correlate with Surgical Radicality and Local Recurrence in Patients with Neuroblastoma.
    Pohl A; Erichsen M; Stehr M; Hubertus J; Bergmann F; Kammer B; von Schweinitz D
    Klin Padiatr; 2016 Apr; 228(3):118-23. PubMed ID: 26930233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy.
    Bagatell R; Rumcheva P; London WB; Cohn SL; Look AT; Brodeur GM; Frantz C; Joshi V; Thorner P; Rao PV; Castleberry R; Bowman LC
    J Clin Oncol; 2005 Dec; 23(34):8819-27. PubMed ID: 16314642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Needle core vs open biopsy for diagnosis of intermediate- and high-risk neuroblastoma in children.
    Hassan SF; Mathur S; Magliaro TJ; Larimer EL; Ferrell LB; Vasudevan SA; Patterson DM; Louis CU; Russell HV; Nuchtern JG; Kim ES
    J Pediatr Surg; 2012 Jun; 47(6):1261-6. PubMed ID: 22703803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity of image-defined risk factors in localized neuroblastoma: A report from two centers in Western Japan.
    Fumino S; Kimura K; Iehara T; Nishimura M; Nakamura S; Souzaki R; Nishie A; Taguchi T; Hosoi H; Tajiri T
    J Pediatr Surg; 2015 Dec; 50(12):2102-6. PubMed ID: 26388125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results of the combination of the N7 induction chemotherapy and the busulfan-melphalan high dose chemotherapy.
    Valteau-Couanet D; Le Deley MC; Bergeron C; Ducassou S; Michon J; Rubie H; Le Teuff G; Coze C; Plantaz D; Sirvent N; Bouzy J; Chastagner P; Hartmann O
    Pediatr Blood Cancer; 2014 Jun; 61(6):977-81. PubMed ID: 23970413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localised and unresectable neuroblastoma in infants: excellent outcome with primary chemotherapy. Neuroblastoma Study Group, Société Française d'Oncologie Pédiatrique.
    Rubie H; Plantaz D; Coze C; Michon J; Frappaz D; Baranzelli MC; Chastagner P; Peyroulet MC; Hartmann O;
    Med Pediatr Oncol; 2001 Jan; 36(1):247-50. PubMed ID: 11464897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of surgery in stage IV neuroblastoma.
    Castel V; Tovar JA; Costa E; Cuadros J; Ruiz A; Rollan V; Ruiz-Jimenez JI; Perez-Hernández R; Cañete A
    J Pediatr Surg; 2002 Nov; 37(11):1574-8. PubMed ID: 12407542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implication of Image-Defined Risk Factors for the Extent of Surgical Resection and Clinical Outcome in Patients with Pelvic Neuroblastoma.
    Froeba-Pohl A; von Schweinitz D; Muehling J; Paolini M; Hubertus J
    Eur J Pediatr Surg; 2021 Aug; 31(4):362-366. PubMed ID: 32862422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of image-defined risk factors for surgical complications in patients with abdominal neuroblastoma.
    Günther P; Holland-Cunz S; Schupp CJ; Stockklausner C; Hinz U; Schenk JP
    Eur J Pediatr Surg; 2011 Oct; 21(5):314-7. PubMed ID: 21780020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer group study.
    Perez CA; Matthay KK; Atkinson JB; Seeger RC; Shimada H; Haase GM; Stram DO; Gerbing RB; Lukens JN
    J Clin Oncol; 2000 Jan; 18(1):18-26. PubMed ID: 10623689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.